About this episode

The episode discusses the Supreme Court case Hikma v. Amarin regarding drug patents and its implications for generic drug companies and patient costs.

The Supreme Court is set to hear Hikma v. Amarin, a battle over drug patents that could raise costs for patients and change the way generic companies do business. Guests: Hans Sauer , adjunct professor, Georgetown Law; former vice president of intellectual property, Biotechnology Innovation Organization Sean Tu , professor of law, University of Alabama Dennies Varughese , partner; Sterne, Kessler, Goldstein and Fox Leslie Walker , senior reporter, Tradeoffs Learn more and read a full transcript on our website . Want more Tradeoffs? Sign up for our free weekly newsletter featuring the latest health policy research and news. Support this type of journalism today, with a gift . Hosted on Acast. See acast.com/privacy for more information.

People in this episode

Guests: Hans Sauer, Sean Tu, Dennies Varughese, Leslie Walker

Topics covered

• Supreme Court
• drug patents
• generic drugs
• health policy
• costs for patients

Keywords

• Supreme Court
• Hikma v. Amarin
• drug patents
• generic drugs
• health policy
• costs
• intellectual property

Mentioned in this episode

Organizations: Georgetown Law, Biotechnology Innovation Organization, University of Alabama, Sterne, Kessler, Goldstein and Fox

More episodes of Tradeoffs

• Call to Mind: The Fifth Branch · May 7, 2026 · 55 min
• New York Braces for Trump's Big Medicaid Shakeup · April 23, 2026 · 24 min
• Should People Who Want GLP-1s Have to Work for Them? · April 16, 2026 · 30 min
• High Health Care Costs Are Fueling a New Fight Over Old Laws · April 9, 2026 · 25 min
• Trump's Pick to Quiet the Chaos at HHS · April 2, 2026 · 21 min
• Inside the Urgent Care Boom · March 19, 2026 · 39 min

Explore listener stats, chart rankings, contacts and more on the Tradeoffs podcast page.